All Stories

  1. Does thyroid diseases contribute to the natural history of idiopathic adult-onset dystonia? Data from the Italian Dystonia Registry
  2. Cortico-spinal tDCS in amyotrophic lateral sclerosis: A randomized, double-blind, sham-controlled trial followed by an open-label phase
  3. Do cerebrovascular risk factors impact the clinical expression of idiopathic isolated adult-onset dystonia?
  4. Survey on antiphospholipid syndrome diagnosis and antithrombotic treatment in patients with ischemic stroke, other brain ischemic injury, or arterial thromboembolism in other sites: communication from ISTH SSC Subcommittee on Lupus Anticoagulant/Antiph...
  5. Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients With COVID-19 Infected With Pre-Omicron Variants
  6. A new national survey of centers for cognitive disorders and dementias in Italy
  7. Sex differences in cerebral venous sinus thrombosis after adenoviral vaccination against COVID-19
  8. Cerebral venous sinus thrombosis due to vaccine-induced immune thrombotic thrombocytopenia in middle-income countries
  9. Phenotypic Variability in Acquired and Idiopathic Dystonia
  10. Global uncertainty in the diagnosis of neurological complications of SARS-CoV-2 infection by both neurologists and non-neurologists: An international inter-observer variability study
  11. Incidence of Syndromes Associated With Frontotemporal Lobar Degeneration in 9 European Countries
  12. A low-dimensional cognitive-network space in Alzheimer’s disease and frontotemporal dementia
  13. Comparative features and outcomes of major neurological complications of COVID ‐19
  14. A low dimensional cognitive-network space in Alzheimer’s disease and frontotemporal dementia
  15. Guillain‐Barré syndrome and COVID ‐19: A 1‐year observational multicenter study
  16. Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease
  17. A snapshot of emergency neurology management in the Lombardy Region, Italy
  18. Prevalence and features of delirium in older patients admitted to rehabilitation facilities: a multicenter study
  19. Short‐ and long‐term outcome and predictors in an international cohort of patients with neuro‐COVID‐19
  20. Accuracy of the clinical diagnosis of dementia with Lewy bodies (DLB) among the Italian Dementia Centers: a study by the Italian DLB study group (DLB-SINdem)
  21. Brain network modulation in Alzheimer's and frontotemporal dementia with transcranial electrical stimulation
  22. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
  23. Probable Silodosin-Induced Diplopia
  24. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
  25. Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
  26. Cerebral microbleeds after COVID-19 infection: an Italian case report
  27. The association between low skeletal muscle mass and delirium: results from the nationwide multi-centre Italian Delirium Day 2017
  28. Visual and Hearing Impairment Are Associated With Delirium in Hospitalized Patients: Results of a Multisite Prevalence Study
  29. Spread of segmental/multifocal idiopathic adult-onset dystonia to a third body site
  30. Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium
  31. Exposure to gamma tACS in Alzheimer’s disease: A randomized, double-blind, sham-controlled, crossover, pilot study
  32. Classification accuracy of TMS for the diagnosis of mild cognitive impairment
  33. Can natural immunity partially replace vaccine against SARS-COV2 infection? A small single center study
  34. Neuroimaging in idiopathic adult-onset focal dystonia
  35. Guillain-Barré syndrome and COVID-19: an observational multicentre study from two Italian hotspot regions
  36. Correction to: Demographic and clinical determinants of neck pain in idiopathic cervical dystonia
  37. Isolate hypoglossal nerve palsy as rare cause of cervical osteophyte
  38. Neurotransmitter imbalance dysregulates brain dynamic fluidity in frontotemporal degeneration
  39. Clinical presentation and outcomes of SARS-CoV-2 related encephalitis: the ENCOVID multicentre study
  40. Expanding the role of education in frontotemporal dementia: a functional dynamic connectivity (the chronnectome) study
  41. Demographic and clinical determinants of neck pain in idiopathic cervical dystonia
  42. Motor and Sensory Features of Cervical Dystonia Subtypes: Data From the Italian Dystonia Registry
  43. Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy
  44. Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome
  45. Effortful speech with distortion of prosody following SARS-CoV-2 infection
  46. Idiopathic Non‐task‐Specific Upper Limb Dystonia, a Neglected Form of Dystonia
  47. The clinical spectrum of encephalitis in COVID-19 disease: the ENCOVID multicentre study
  48. Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia
  49. TMS for staging and predicting functional decline in frontotemporal dementia
  50. Neurophysiological Correlates of Positive and Negative Symptoms in Frontotemporal Dementia
  51. Does acute peripheral trauma contribute to idiopathic adult-onset dystonia?
  52. Classification Accuracy of Transcranial Magnetic Stimulation for the Diagnosis of Neurodegenerative Dementias
  53. Granulomatosis with polyangiitis presenting with pachymeningitis and persistent headache
  54. Transcranial stimulation in frontotemporal dementia: A randomized, double‐blind, sham‐controlled trial
  55. Transcranial magnetic stimulation and amyloid markers in mild cognitive impairment: impact on diagnostic confidence and diagnostic accuracy
  56. Acute venous thrombosis of inferior cerebellar vein, case report
  57. Cortico-spinal tDCS in ALS: A randomized, double-blind, sham-controlled trial
  58. Stimulation over the cerebellum with a regular figure-of-eight coil induces reduced motor cortex inhibition in patients with progressive supranuclear palsy
  59. Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR
  60. Clinical and neurophysiological characteristics of heterozygous NPC1 carriers
  61. Transient coma as Percheron’s artery stroke
  62. Clinical and biomarker changes in presymptomatic genetic frontotemporal dementia
  63. Multicentre, population-based, case–control study of particulates, combustion products and amyotrophic lateral sclerosis risk
  64. 081. SPONTANEOUS SPINAL SUBDURAL HEMATHOMA AS A MANIFESTATION OF ANCA-ASSOCIATED VASCULITIS
  65. Transcranial direct current stimulation enhances theory of mind in Parkinson’s disease patients with mild cognitive impairment: a randomized, double-blind, sham-controlled study
  66. Mild symptomatic Wernicke’s Encephalopathy: a case report
  67. Transcranial direct current stimulation combined with cognitive training for the treatment of Parkinson Disease: A randomized, placebo-controlled study
  68. The impact of transcranial magnetic stimulation on diagnostic confidence in patients with Alzheimer disease
  69. Cerebello-spinal tDCS in ataxia
  70. Diagnosis of Mild Cognitive Impairment Due to Alzheimer’s Disease with Transcranial Magnetic Stimulation
  71. Association between alcohol exposure and the risk of amyotrophic lateral sclerosis in the Euro-MOTOR study
  72. Multicentre, cross-cultural, population-based, case–control study of physical activity as risk factor for amyotrophic lateral sclerosis
  73. Correction to: The Italian Dystonia Registry: rationale, design and preliminary findings
  74. Bilateral tunnel vision as the first presenting sign of levamisole-induced vasculitis
  75. Recent neuroimaging, neurophysiological, and neuropathological advances for the understanding of NPC
  76. Trauma and amyotrophic lateral sclerosis: a european population-based case-control study from the EURALS consortium
  77. Mendelian forms of disease and age at onset affect survival in frontotemporal dementia
  78. A case-control study of hormonal exposures as etiologic factors for ALS in women
  79. Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia
  80. Long term clinical and neurophysiological effects of cerebellar transcranial direct current stimulation in patients with neurodegenerative ataxia
  81. The Italian Dystonia Registry: rationale, design and preliminary findings
  82. Preliminary Results on Long-Term Potentiation-Like Cortical Plasticity and Cholinergic Dysfunction After Miglustat Treatment in Niemann-Pick Disease Type C
  83. Association of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly
  84. Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment
  85. Is firstly diagnosed ALS really ALS? Results of a population-based study with long-term follow-up
  86. The Italian dementia with Lewy bodies study group (DLB-SINdem): toward a standardization of clinical procedures and multicenter cohort studies design
  87. Impaired long‐term potentiation–like cortical plasticity in presymptomatic genetic frontotemporal dementia
  88. Frontotemporal dementia and language networks: cortical thickness reduction is driven by dyslexia susceptibility genes
  89. Functional Connectivity Networks in Asymptomatic and SymptomaticDYT1Carriers
  90. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
  91. Subcortical matter in the α-synucleinopathies spectrum: an MRI pilot study
  92. White matter hyperintensities characterize monogenic frontotemporal dementia with granulin mutations
  93. Erythropoietin: a new perspective in cardiovascular therapy
  94. Do Beliefs about the Pathogenetic Role of Amyloid Affect the Interpretation of Amyloid PET in the Clinic?
  95. Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy
  96. Extrapyramidal and cognitive signs in amyotrophic lateral sclerosis: A population based cross-sectional study
  97. Prevalence of Asymptomatic Vertebral Fractures in Late-Onset Pompe Disease
  98. Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study
  99. Phenotypic heterogeneity of Niemann–Pick disease type C in monozygotic twins
  100. Italian Frontotemporal Dementia Network (FTD Group-SINDEM): sharing clinical and diagnostic procedures in Frontotemporal Dementia in Italy
  101. Strategies for treating mitochondrial disorders: An update
  102. Late-Onset Glycogen Storage Disease Type 2
  103. Plasma amino acids patterns and age of onset of amyotrophic lateral sclerosis
  104. Physical activity and amyotrophic lateral sclerosis: A European population-based case-control study
  105. Long-term survival in amyotrophic lateral sclerosis: A population-based study
  106. A complex craniovertebral junction malformation in a patient with late onset glycogenosis 2
  107. Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset
  108. Choreo-athetosis in LRRK2 R1441C mutation: Expanding the clinical phenotype
  109. The Role of Brain MRI in Mitochondrial Neurogastrointestinal Encephalomyopathy
  110. MR Neurography in Diagnosing Nondiabetic Lumbosacral Radiculoplexus Neuropathy
  111. The brain in late-onset glycogenosis II: a structural and functional MRI study
  112. Hemangioma of the semimembranosus muscle in a patient with late-onset glycogenosis II
  113. Clinical Spectrum and Evolution of Monoclonal Gammopathy-associated Neuropathy
  114. Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy
  115. Trauma and amyotrophic lateral sclerosis: a case-control study from a population-based registry
  116. Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency with unknown genetic defect
  117. Coffee and Amyotrophic Lateral Sclerosis: A Possible Preventive Role
  118. The role of mitochondria in neurodegenerative diseases
  119. Pitfalls in diagnosing mitochondrial neurogastrointestinal encephalomyopathy
  120. Involvement of the central nervous system myelin in a POEMS patient
  121. Current Options in the Treatment of Mitochondrial Diseases
  122. Limb-Girdle Muscular Dystrophy-Associated Protein Diseases
  123. Idiopathic hypocomplementemic urticarial vasculitis-linked neuropathy
  124. High sensitivity C-reactive protein: a predictor for recurrence of atrial fibrillation after successful cardioversion
  125. Chronic ophthalmoparesis in limb girdle muscular dystrophy 1C
  126. Disulfiram neuropathy: Two cases of distal axonopathy
  127. Nitric oxide and cardiovascular risk factors
  128. Diagnostic value of the head-up tilt test and the R-test in patients with syncope